下載本文檔
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、 HYPERLINK https:/www.MedChemE/Targets/Melatonin Receptor.html Melatonin HYPERLINK https:/www.MedChemE/Targets/Melatonin Receptor.html HYPERLINK https:/www.MedChemE/Targets/Melatonin Receptor.html ReceptorMelatonin receptors belong to the G protein-coupled receptor superfamily, which preferentially
2、couple to G proteins. Thei/omelatonin receptor subfamily is composed of three members in mammals: MT and MT , which are both binding to the1 2neurohormone melatonin with high affinity, and GPR50, which shows high sequence homology to MT and MT but does not bind1 2to melatonin or any other known liga
3、nd.MT and MT are involved in various biological functions including the regulation of biological rhythms, sleep, pain, retinal, neuronal1 2and immune functions. Alteration of melatonin receptor function or expression in humans is associated with depression,Alzheimers disease and type 2 diabetes.www.
4、MedChemE 1 HYPERLINK https:/www.MedChemE/Targets/Melatonin Receptor.html Melatonin HYPERLINK https:/www.MedChemE/Targets/Melatonin Receptor.html HYPERLINK https:/www.MedChemE/Targets/Melatonin Receptor.html Receptor HYPERLINK https:/www.MedChemE/Targets/Melatonin Receptor.html HYPERLINK https:/www.M
5、edChemE/Targets/Melatonin Receptor.html Agonists, HYPERLINK https:/www.MedChemE/Targets/Melatonin Receptor.html HYPERLINK https:/www.MedChemE/Targets/Melatonin Receptor.html Activators HYPERLINK https:/www.MedChemE/Targets/Melatonin Receptor.html HYPERLINK https:/www.MedChemE/Targets/Melatonin Recep
6、tor.html & HYPERLINK https:/www.MedChemE/Targets/Melatonin Receptor.html HYPERLINK https:/www.MedChemE/Targets/Melatonin Receptor.html Antagonists HYPERLINK https:/www.MedChemE/2-iodomelatonin.html 2-Iodomelatonin HYPERLINK https:/www.MedChemE/2-iodomelatonin.html HYPERLINK https:/www.MedChemE/4-p-p
7、dot.html 4-P-PDOTCat. No.: HY-101176 Cat. No.: HY-1006092-Iodomelatonin is a potent agonist ofmelatonin receptor 1 (MT1) with a K valueiof 28 pM, it is more 5-fold selective for MT1over MT . 2-iodomelatonin can be used to2identify, characterize and localize melatoninbinding sites in the brain and pe
8、ripheral tissues.4-P-PDOT is a potent, selective and affinityMelatonin receptor (MT2) antagonist.4-P-PDOT is 300-fold more selective for MT2than MT1.Purity: 99.0%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 1 mg, 5 mg, 10 mgPurity: 99.45%Clinical Data: No Development ReportedSize: 10 mM 1
9、 mL, 1 mg, 5 mg HYPERLINK https:/www.MedChemE/6-chloromelatonin.html 6-ChloromelatoninCat. No.: HY-100940 HYPERLINK https:/www.MedChemE/7-desmethyl-3-hydroxyagomelatine.html 7-Desmethyl-3-hydroxyagomelatine(3-Hydroxy-7-desmethyl agomelatine) Cat. No.: HY-1331126-Chloromelatonin is a potent melatonin
10、receptor agonist with greater metabolic stabilitythan melatonin. 6-Chloromelatonin compete for3H-melatonin and 2-125I-iodomelatoninbinding to MT1 receptors (pK=8.9 and 9.1,irespectively).7-Desmethyl-3-hydroxyagomelatine(3-Hydroxy-7-desmethyl agomelatine), a metaboliteof Agomelatine, has less activit
11、y thanAgomelatine. Agomelatine is a melatonergic(MT1 and MT2) agonist and serotonergic(5HT2C) antagonist.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/7-desmethyl-3-hydroxyagomelatine-d
12、3.html 7-Desmethyl-3-hydroxyagomelatine-d3(3-Hydroxy-7-desmethyl agomelatine-d3) Cat. No.: HY-133112S HYPERLINK https:/www.MedChemE/8-m-pdot.html 8-M-PDOT(AH-002) Cat. No.: HY-1013587-Desmethyl-3-hydroxyagomelatine-d3(3-Hydroxy-7-desmethyl agomelatine-d3) is thedeuterium labeled7-Desmethyl-3-hydroxy
13、agomelatine.8-M-PDOT (AH-002) is a selective melatonin MT2receptor agonist. 8-M-PDOT is 5.2-fold selectivefor MT2 over MT1 receptors. 8-M-PDOT bindshuman recombinant MT2 and MT2 receptors withpKi values of 8.23 and 8.95 respectively. 8-M-PDOThas anxiolytic-like activity.Purity: 98%Clinical Data: No
14、Development ReportedSize: 1 mg, 5 mgPurity: 98.48%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 10 mg HYPERLINK https:/www.MedChemE/ach-000143.html ACH-000143 HYPERLINK https:/www.MedChemE/ach-000143.html HYPERLINK https:/www.MedChemE/agomelatin-d3.html Agomelatin-d3Cat. No.: HY-138626(S-2
15、0098-d3) Cat. No.: HY-17038S2ACH-000143 is a potent and orally activemelatonin receptor agonist, with EC values50of 0.06 nM and 0.32 nM for MT1 and MT2,respectively.Agomelatin-d3 (S-20098-d3) is the deuteriumlabeled Agomelatine. Agomelatine (S-20098) is aspecific agonist of MT1 and MT2 receptorswith
16、 Ks of 0.1, 0.06, 0.12, and 0.27 nM foriCHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2,respectively.Purity: 98.65%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/Agome
17、latine.html Agomelatine HYPERLINK https:/www.MedChemE/Agomelatine.html HYPERLINK https:/www.MedChemE/agomelatine-l_addition_-tartaric-acid.html Agomelatine HYPERLINK https:/www.MedChemE/agomelatine-l_addition_-tartaric-acid.html HYPERLINK https:/www.MedChemE/agomelatine-l_addition_-tartaric-acid.htm
18、l (L(+)-Tartaric HYPERLINK https:/www.MedChemE/agomelatine-l_addition_-tartaric-acid.html HYPERLINK https:/www.MedChemE/agomelatine-l_addition_-tartaric-acid.html acid)(S-20098) Cat. No.: HY-17038 (S-20098 L(+)-Tartaric acid) Cat. No.: HY-17038BAgomelatine (S-20098) is a specific agonist ofMT1 and M
19、T2 receptors with Ks of 0.1, 0.06,i0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1,CHO-hMT2, and HEK-hMT2, respectively.Agomelatine L(+)-Tartaric acid (S-20098L(+)-Tartaric acid) is a specific agonist ofMT1 and MT2 receptors with Ks of 0.1, 0.06,i0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1,CHO-hMT2, and HEK-h
20、MT2, respectively.Purity: 98.77%Clinical Data: LaunchedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity: 99.82%Clinical Data: LaunchedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/agomelatine-hydrochloride.html
21、Agomelatine HYPERLINK https:/www.MedChemE/agomelatine-hydrochloride.html HYPERLINK https:/www.MedChemE/agomelatine-hydrochloride.html hydrochloride(S-20098 hydrochloride) Cat. No.: HY-17038A HYPERLINK https:/www.MedChemE/agomelatine-d4.html Agomelatine-d4(S-20098-d4) Cat. No.: HY-17038S1Agomelatine
22、hydrochloride (S-20098 hydrochloride)is a specific agonist of MT1 and MT2receptors with Ks of 0.1, 0.06, 0.12, and 0.27 nMifor CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2,respectively.Agomelatine-d4 (S-20098-d4) is the deuteriumlabeled Agomelatine. Agomelatine (S-20098) is aspecific agonist of MT1 an
23、d MT2 receptorswith Ks of 0.1, 0.06, 0.12, and 0.27 nM foriCHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2,respectively.Purity: 99.55%Clinical Data: LaunchedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 10 mg HYPERLINK https:/www.MedChemE/agomela
24、tine-d6.html Agomelatine-d6(S-20098-d6) Cat. No.: HY-17038S HYPERLINK https:/www.MedChemE/dh97.html DH97Cat. No.: HY-107628Agomelatine-d6 (S-20098-d6) is deuterium labeledAgomelatine. Agomelatine is a specific agonist ofMT1 and MT2 receptors .DH97 is a potent and selective antagonist ofMT melatonin
25、receptor2 , with a pKi of 8.03for human MT . DH97 shows 89- and 229-fold2selectivity for human MT over human mt and2 1Xenopus mel receptor subtypes.1cPurity: 98%Clinical Data: No Development ReportedSize: 1 mgPurity: 98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg HYPERLINK
26、https:/www.MedChemE/luzindole.html Luzindole(N-0774) Cat. No.: HY-101254 HYPERLINK https:/www.MedChemE/Melatonin.html Melatonin(N-Acetyl-5-methoxytryptamine) Cat. No.: HY-B0075Luzindole (N-0774) is a selective melatoninreceptor antagonist. Luzindole preferentiallytargets MT2 (Mel ) over MT1 (Mel ) w
27、ith1b 1a Kivalues of 10.2 and 158 nM for human MT2 and MT1,respectively.Melatonin is a hormone made by the pineal glandthat can activates melatonin receptor.Melatonin plays a role in sleep and possessesimportant antioxidative and anti-inflammatoryproperties.Purity: 100.0%Clinical Data: No Developmen
28、t ReportedSize: 10 mM 1 mL, 1 mg, 5 mg, 10 mgPurity: 99.73%Clinical Data: LaunchedSize: 10 mM 1 mL, 500 mg, 1 g, 5 g HYPERLINK https:/www.MedChemE/melatonin-d3.html Melatonin-d3 HYPERLINK https:/www.MedChemE/melatonin-d3.html HYPERLINK https:/www.MedChemE/melatonin-d5.html Melatonin-d4(N-Acetyl-5-me
29、thoxytryptamine-d3) Cat. No.: HY-B0075S1 (N-Acetyl-5-methoxytryptamine-d4) Cat. No.: HY-B0075SMelatonin-d3 (N-Acetyl-5-methoxytryptamine-d3) isthe deuterium labeled Melatonin. Melatonin is ahormone made by the pineal gland that canactivates melatonin receptor.Melatonin D4 is deuterium labeled Melato
30、nin.Melatonin is a hormone made by the pineal glandthat can activates melatonin receptor.Antioxidative and anti-inflammatory properties.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 95.87%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg HYPERLINK https:/www.Me
31、dChemE/melatonin-d7.html Melatonin-d7 HYPERLINK https:/www.MedChemE/melatonin-d7.html HYPERLINK https:/www.MedChemE/n-acetyltryptamine.html N-Acetyltryptamine HYPERLINK https:/www.MedChemE/n-acetyltryptamine.html (N10-Acetyltryptamine;(N-Acetyl-5-methoxytryptamine-d7) Cat. No.: HY-B0075S2 Nb-Acetylt
32、ryptamine; N-Acetyltryptamine) Cat. No.: HY-100908Melatonin-d7 (N-Acetyl-5-methoxytryptamine-d7) isthe deuterium labeled Melatonin. Melatonin is ahormone made by the pineal gland that canactivates melatonin receptor.N-Acetyltryptamine is a partial agonist formelatonin receptors in the retina.N-Acety
33、ltryptamine is also used for determinationof serotonin N-acetyl transferase activity.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgwww.MedChemE 3 HYPERLINK https:/www.MedChemE/piromelatine.html Piromelatine(Ne
34、u-P11) Cat. No.: HY-105285 HYPERLINK https:/www.MedChemE/ramelteon.html Ramelteon(TAK-375) Cat. No.: HY-A0014Piromelatine (Neu-P11) is a melatoninMT1/MT2 receptor agonist, serotonin5-HT1A/5-HT1D agonist, and serotonin 5-HT2Bantagonist.Ramelteon is a potent, highly selective, andorally active agonist
35、 of MT1/MT2 with Ki valuesof 14 and 112 pM, respectively. Ramelteon has thepotential for the research of insomnia.Purity: 99.21%Clinical Data: Phase 2Size: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity: 99.87%Clinical Data: LaunchedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mg, 500 mg HYPERLINK https:
36、/www.MedChemE/Ramelteon_metabolite_M-II.html Ramelteon HYPERLINK https:/www.MedChemE/Ramelteon_metabolite_M-II.html HYPERLINK https:/www.MedChemE/Ramelteon_metabolite_M-II.html metabolite HYPERLINK https:/www.MedChemE/Ramelteon_metabolite_M-II.html HYPERLINK https:/www.MedChemE/Ramelteon_metabolite_
37、M-II.html M-II HYPERLINK https:/www.MedChemE/Ramelteon_metabolite_M-II.html HYPERLINK https:/www.MedChemE/ramelteon-metabolite-m-ii-d3.html Ramelteon HYPERLINK https:/www.MedChemE/ramelteon-metabolite-m-ii-d3.html HYPERLINK https:/www.MedChemE/ramelteon-metabolite-m-ii-d3.html metabolite HYPERLINK h
38、ttps:/www.MedChemE/ramelteon-metabolite-m-ii-d3.html HYPERLINK https:/www.MedChemE/ramelteon-metabolite-m-ii-d3.html M-II-d3Cat. No.: HY-103005 Cat. No.: HY-103005SRamelteon metabolite M-II is the major metaboliteof Ramelteon, with IC s of 208 pM, 1470 pM for50human melatonin receptors (MT or MT ).1
39、 2Ramelteon is a selective melatonin agonist.Ramelteon metabolite M-II-d3 is the deuteriumlabeled Ramelteon metabolite M-II. Ramelteonmetabolite M-II is the major metabolite ofRamelteon, with IC s of 208 pM, 1470 pM for human50melatonin receptors (MT or MT ). Ramelteon1 2is a selective melatonin ago
40、nist.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 10 mg HYPERLINK https:/www.MedChemE/ramelteon-d5.html Ramelteon-d5(TAK-375-d5) Cat. No.: HY-A0014S HYPERLINK https:/www.MedChemE/s-22153.html S-22153Cat. No.: HY-114962R
41、amelteon-d5 is deuterium labeled Ramelteon.Ramelteon is a potent, highly selective, andorally active agonist of MT1/MT2 with Ki values of14 and 112 pM, respectively. Ramelteon has thepotential for the research of insomnia.S-22153 is a potent melatonin receptorantagonist with EC values of 19 nM, 4.6
42、nM for50hMT1 and hMT2 melatonin receptor,respectively.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/s26131.html S26131 HYPERLINK https:/www.MedChemE/s26131.html H
43、YPERLINK https:/www.MedChemE/Tasimelteon.html TasimelteonCat. No.: HY-122136(BMS-214778; VEC-162) Cat. No.: HY-14803S26131 (compound 5) is a potent and selectiveMT1 melatoninergic ligand, and the K valuesiare 0.5 and 112 nM for MT1 and MT2, respectively.S26131 behaves as an MT1 and MT2 antagonist.Tasimelteon (BMS-214778) is an orally active andselective dual melatonin receptor agonist(DMRA). Tasimelteon has 2.1-4.4 times greateraffinity for the MT2 receptor than f
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2024年度酒店預(yù)訂押金協(xié)議范本3篇
- 2024原材料運(yùn)輸及倉儲(chǔ)一體化服務(wù)合同3篇
- 2024養(yǎng)老院老年社交活動(dòng)策劃與執(zhí)行合同3篇
- 2024年新能源電池組裝外加工合作協(xié)議3篇
- 2024年度水電工程設(shè)計(jì)與施工一體化服務(wù)合同3篇
- 《聯(lián)想集團(tuán)有限公司》課件
- 物業(yè)應(yīng)急突發(fā)事件培訓(xùn)
- 建材加工合同范例
- 購房定金合同范例范例
- 瓷粉質(zhì)量購買合同范例
- 體育宣傳視頻分析-NBA全明星賽廣告分析
- 2024年安全文化建設(shè)實(shí)施方案
- 康復(fù)治療技術(shù)歷年真題單選題100道及答案
- 2024年領(lǐng)導(dǎo)干部和公務(wù)員法律法規(guī)應(yīng)知應(yīng)會(huì)知識(shí)考試題庫
- 醫(yī)生給病人免責(zé)協(xié)議書(2篇)
- 【格力電器應(yīng)收賬款管理存在的問題及優(yōu)化建議探析(論文)12000字】
- 透鏡及其應(yīng)用??家族e(cuò)陷阱分析-2024年中考物理考試易錯(cuò)題
- 記賬實(shí)操-紅十字會(huì)的會(huì)計(jì)賬務(wù)處理分錄
- 空運(yùn)陸運(yùn)操作崗位招聘面試題及回答建議(某大型國企)2024年
- 《元旦新氣象夢(mèng)想再起航》主題班會(huì)
- 2024年P(guān)MP項(xiàng)目管理師考試試卷及答案指導(dǎo)
評(píng)論
0/150
提交評(píng)論